Document
IPR2017-00190, No. 1523-172 Exhibit - Kaken Research Development Division RD Pipeline (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1523-172 Exhibit - Kaken Research Development Division RD Pipeline (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2054-101 Exhibit - Kaken Exhibit 2054 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2054-101 Exhibit - Kaken Exhibit 2054 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2086-132 Exhibit - Kaken Exhibit 2086 (P.T.A.B. Aug. 1, 2017)
Cite Document
IPR2017-00190, No. 2086-132 Exhibit - Kaken Exhibit 2086 (P.T.A.B. Aug. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1656-305 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations Search results for Tavaborole, (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1656-305 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations Search results for Tavaborole, (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1516-165 Exhibit - Label for Diflucan¿¿ fluconazole tablets, Pfizer Inc, NDA 19 949 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1516-165 Exhibit - Label for Diflucan¿¿ fluconazole tablets, Pfizer Inc, NDA 19 949 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1020-20 Exhibit - Quintanar Guerrero, D et al, Drug Dev Ind Pharm, 24 685 690 1998 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1020-20 Exhibit - Quintanar Guerrero, D et al, Drug Dev Ind Pharm, 24 685 690 1998 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1615-264 Exhibit - Creating Demand for Prescription Drugs A Content Analysis of Television Direct to Consumer Advertising (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1615-264 Exhibit - Creating Demand for Prescription Drugs A Content Analysis of Television Direct to Consumer Advertising (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1608-257 Exhibit - Valeant Pharmaceuticals International, Inc, 2015 JP Morgan Healthcare Conference, dated January 13, 2015 (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1608-257 Exhibit - Valeant Pharmaceuticals International, Inc, 2015 JP Morgan Healthcare Conference, dated January 13, 2015 (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 2023-70 Exhibit - Kaken Exhibit 2023 (P.T.A.B. Jul. 18, 2017)
Cite Document
IPR2017-00190, No. 2023-70 Exhibit - Kaken Exhibit 2023 (P.T.A.B. Jul. 18, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1002-2 Exhibit - Certified English Translation of Japanese Pat App No 11214369 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1002-2 Exhibit - Certified English Translation of Japanese Pat App No 11214369 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1046-46 Exhibit - Acrux DDS Pty Ltd Corporate Website (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1046-46 Exhibit - Acrux DDS Pty Ltd Corporate Website (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1560-209 Exhibit - Two are Charged in Fraud and Kickback Scheme Against Valeant Pharmaceuticals (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1560-209 Exhibit - Two are Charged in Fraud and Kickback Scheme Against Valeant Pharmaceuticals (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1025-25 Exhibit - Heine, C AdWeek Jan 27, 2015 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1025-25 Exhibit - Heine, C AdWeek Jan 27, 2015 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1009-9 Exhibit - Comparison between the Priority Document (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1009-9 Exhibit - Comparison between the Priority Document (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1535-184 Exhibit - Pharmacy Benefit Management Are Reporting Requirements Pro or Anticompetitive (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1535-184 Exhibit - Pharmacy Benefit Management Are Reporting Requirements Pro or Anticompetitive (P.T.A.B. Nov. 1, 2017)
+ More Snippets